Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes - Tin, A S; Sundar, S N; Tran, K Q (Anticancer Drugs, 2012)
et al.